Antacids Market 2024-2028: Size and Adverse effect of prolonged use of antacids; growth driven by the Type, Some of key Companies Positioned Strategically

The antacids market size by Type (Non-symmetric antacids and Symmetric antacids) and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 692.3 million. The market is expected to grow at a CAGR of   3.27% between 2024 and 2028.

• Antacids are essential medications used to neutralize excess stomach acid, providing relief for individuals experiencing symptoms of heartburn, dyspepsia, and gastroesophageal reflux disease (GERD). However, prolonged use or excessive intake of certain antacids, such as Maalox, Mylanta, Rolaids, and TUMS, which contain calcium, can pose health risks. Specifically, calcium overdose may occur, leading to adverse effects including nausea, vomiting, mood fluctuations, kidney stones, gas or belching, laxative effect, and swelling of the feet and ankles. Furthermore, antacids may contribute to the development of metabolic alkalosis and rebound acidity due to dose dependence. Antacids consisting of aluminum hydroxide can cause constipation, aluminum intoxication, osteocalcin, and hypophosphatemia. In contrast, magnesium-containing antacids may result in diarrhea due to their laxative effect. It is crucial for patients to adhere to the recommended dosages and consult their healthcare providers for appropriate antacid use to mitigate potential risks.
• The antacids market represents a significant business opportunity due to the rising prevalence of gastroesophageal reflux disease (GERD) and other digestive disorders. These conditions lead to frequent heartburn and acid reflux, driving demand for antacids. Key market players are investing in research and development to introduce innovative products, such as delayed-release formulations and combination therapies, to cater to diverse consumer needs. The market is expected to grow steadily, driven by increasing consumer awareness and healthcare expenditures.

Access the full report to know who are the other key countries segment-wise forecast and historic data

Some of the Key Companies:

• Advance Pharmaceutical Inc.
• AmerisourceBergen Corp.
• Bayer AG
• Cardinal Health Inc.
• GlaxoSmithKline Plc
• Humco Holding Group Inc.
• inovapharma.com
• Johnson and Johnson Services Inc.
• Neogen Corp.
• Novartis AG
• NuCare Laboratories India
• Pfizer Inc.
• Pharmaceutical Associates Inc.
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• The Procter and Gamble Co.
• United Natural Foods Inc.
• WellSpring Pharmaceutical Corp.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/